Subrata Panda &Amp; Sohini Das

Stories by Subrata Panda &Amp; Sohini Das

UPI Jan volume up 77% to 2.3 bn year-on-year, value doubles to Rs 4.3 trn

UPI Jan volume up 77% to 2.3 bn year-on-year, value doubles to Rs 4.3 trn

Rediff.com   4 Feb 2021

While it took UPI three years to reach a billion transactions in a month, the next billion came in just a year. Digital payments, especially UPI, saw increased adoption in 2020 due to the Covid-19 pandemic.

RBI to crack whip on recovery agents, calls for restricting messaging apps

RBI to crack whip on recovery agents, calls for restricting messaging apps

Rediff.com   28 Jan 2021

Digital lending apps extend small amounts at exorbitant rates. Payment delays invite messages to customer or close family members, often with sensitive information such as Aadhaar and PAN Card scans.

Centre, states team up with RBI, Big Tech to fight Chinese lending apps

Centre, states team up with RBI, Big Tech to fight Chinese lending apps

Rediff.com   22 Jan 2021

A user just needs to download any app floated by such fraudsters and apply for instant loans. These apps are mainly concentrated on Google Play considering the reach and popularity of Android systems.

PhonePe beats Google Pay, tops UPI app space in December

PhonePe beats Google Pay, tops UPI app space in December

Rediff.com   19 Jan 2021

These top two apps account for more than 78 per cent of the UPI market in terms of volume of transaction, and 86 per cent of the market by value of transactions in December.

Why early applicant Pfizer's Covid vaccine is delayed

Why early applicant Pfizer's Covid vaccine is delayed

Rediff.com   19 Jan 2021

Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.

Serum Institute may supply 400 million doses to Gavi-Covax

Serum Institute may supply 400 million doses to Gavi-Covax

Rediff.com   19 Jan 2021

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com   18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

Serum Institute began its journey in a small lab in stud farm

Serum Institute began its journey in a small lab in stud farm

Rediff.com   16 Jan 2021

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.

Growth in health insurance segment slows as fear of Covid-19 subsides

Growth in health insurance segment slows as fear of Covid-19 subsides

Rediff.com   13 Jan 2021

Irdai had introduced two Covid specific products in the market - Corona Kavach and Corona Rakshak - that saw huge acceptance among the consumers as these products had lower premiums.

UPI breached 2 billion transactions 3 months in a row

UPI breached 2 billion transactions 3 months in a row

Rediff.com   12 Jan 2021

Surge in UPI transactions is because of an increased consumer interest in making bill payments and recharging mobile phones online, and purchase of non-essential goods on e-commerce platforms.

'It'll take 3-4 years to vaccinate 80% of population'

'It'll take 3-4 years to vaccinate 80% of population'

Rediff.com   11 Jan 2021

'We are hoping by March, the government allows us to export and give it to the private market.'

Soon you can buy insurance at petrol pumps, gas agencies

Soon you can buy insurance at petrol pumps, gas agencies

Rediff.com   9 Jan 2021

This will help expand the distribution channels, said Subhash Chandra Khuntia, chairman of the insurance regulatory and development authority of India.

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Mutual funds set for digital disruption

Mutual funds set for digital disruption

Rediff.com   31 Dec 2020

Mutual funds aspirants have the option of snapping up smaller AMCs or applying for a new licence.

Kids will have to wait for a COVID-19 vaccine

Kids will have to wait for a COVID-19 vaccine

Rediff.com   28 Dec 2020

The primary objective was to get the adult vaccine as children rarely have a severe form of the disease. Once schools reopen, the demand for vaccines for children under 12 may soar.

COVID vaccine: States to use bank guarantees

COVID vaccine: States to use bank guarantees

Rediff.com   26 Dec 2020

Each of the larger states may need less than Rs 10,000 crore each to finance the exercise.

Centre may not get costly Pfizer vaccine

Centre may not get costly Pfizer vaccine

Rediff.com   22 Dec 2020

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.

4 show interest in PMC's EoI; curbs to stay till March

4 show interest in PMC's EoI; curbs to stay till March

Rediff.com   21 Dec 2020

In its EoI document, the bank had said it was open to converting into a small finance bank.

'Demand for home loans is rising steadily'

'Demand for home loans is rising steadily'

Rediff.com   19 Dec 2020

'We tightened our risk frameworks once the Covid crisis started.' 'We are slowly lightening this as we see economic activity pick up, salaries getting restored, and people getting back into jobs.'